Liquid biopsy in resistance surveillance of ALKi – Video abstract [ID 151235] скачать в хорошем качестве

Liquid biopsy in resistance surveillance of ALKi – Video abstract [ID 151235]

Video abstract of a review paper “The applications of liquid biopsy in resistance surveillance of anaplastic lymphoma kinase inhibitor” published in the open access journal Cancer Management and Research by Chen et al With the clinical promotion of precision medicine and individualized medical care, molecular targeted medicine has been used to treat non-small cell lung cancer (NSCLC) patients and proved to be significantly effective. Anaplastic lymphoma kinase (ALK) inhibitor is one of the most important specific therapeutic agents for patients with ALK-positive NSCLC. It can extend the survival of patients. However, resistance to the ALK inhibitor inevitably develops in the application process. So, the real-time resistance surveillance is particularly important, and liquid biopsy is one of the most potential inspection methods. Circulating tumor cells, circulating free tumor DNA and exosome in body fluid are used as the main detection biomarkers to reflect the occurrence of resistance in real time through sequencing or counting and then to guide the follow-up treatment. Read the review paper here https://www.dovepress.com/the-applica...